Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low?
Open Access
- 1 February 2010
- journal article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 10 (2), 133-137
- https://doi.org/10.1016/s1473-3099(10)70004-9
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Integrating epidemiology, psychology, and economics to achieve HPV vaccination targetsProceedings of the National Academy of Sciences of the United States of America, 2008
- Evaluating human papillomavirus vaccination programs in Canada: should provincial healthcare pay for voluntary adult vaccination?BMC Public Health, 2008
- Human Papilloma Virus vaccine and cervical cancer screening acceptability among adults in Quebec, CanadaBMC Public Health, 2007
- Human Papillomavirus and Papanicolaou Tests to Screen for Cervical CancerNew England Journal of Medicine, 2007
- Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young womenInfectious Agents and Cancer, 2007
- Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysisThe Lancet Infectious Diseases, 2007
- Model for Assessing Human Papillomavirus Vaccination StrategiesEmerging Infectious Diseases, 2007
- Chapter 13: Current findings from prophylactic HPV vaccine trialsVaccine, 2006
- Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling AnalysesPLoS Medicine, 2006
- Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysisBritish Journal of Cancer, 2003